Hepatitis C Management in Special Populations

  • Author: Mark S. Sulkowski, MD (More Info)
  • Editor In Chief: Stefan Zeuzem, MD
  • Last Reviewed: 8/17/18 (What's New)

Summary

  • Women of reproductive age who have been diagnosed with HCV infection should be counseled about the benefit of antiviral treatment before pregnancy
  • Treatment with DAAs during pregnancy is not recommended as only limited safety and efficacy data are available (Management Guidelines)[AASLD-IDSA HCV; Chappell 2020]
  • Ribavirin is contraindicated in pregnancy due to its known teratogenic effects

    Action required